Nevertheless, a growing body of research indicates that ULK2 is downregulated in various tumor types (Liu & Wei, 2023), exerting inhibitory effects on tumor initiation and progression (Shukla et al., 2014). This evidence concerns the gene ULK2 and neoplasm.